Cerebrospinal fluid biomarkers for the differential diagnosis of Alzheimer's disease
ABSTRACT Introduction: Several studies have been conducted in order to validate cerebrospinal fluid biomarkers for the diagnosis of Alzheimer's disease (AD), aiming primarily to facilitate the early diagnosis. Objective: To evaluate CSF biomarkers on patients with probable AD and the applicabil...
Saved in:
Main Authors: | Carolina A. Magalhães (Author), Micheli Figueiró (Author), Vanessa G. Fraga (Author), Elvis C. Mateo (Author), André A. S. F. Toledo (Author), Maria das Graças Carvalho (Author), Paulo Caramelli (Author), Karina B. Gomes (Author) |
---|---|
Format: | Book |
Published: |
Sociedade Brasileira de Patologia Clínica,
2015-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The meaning of blood and cerebrospinal fluid biomarkers in early diagnosis of Alzheimer's disease
by: Julita Szarpak, et al.
Published: (2020) -
Impacts of CR1 genetic variants on cerebrospinal fluid and neuroimaging biomarkers in alzheimer's disease
by: Xi-chen Zhu, et al.
Published: (2020) -
Cerebrospinal fluid lactate: a differential biomarker for bacterial and viral meningitis in children
by: Mudasir Nazir, et al.
Published: (2018) -
Cerebrospinal fluid lactate: a differential biomarker for bacterial and viral meningitis in children
by: Mudasir Nazir, et al.
Published: (2018) -
Cerebrospinal fluid lactate: a differential biomarker for bacterial and viral meningitis in children
by: Mudasir Nazir, et al.